SCHEMBL20113437

SCHEMBL20113437

C=C(CP(=O)(c1ccccc1)c1ccccc1)P1(=S)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
USP2 O75604 1/20 0.42
ALDH1A1 P00352 3/20 0.42
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
MAPT P10636 2/20 0.37
ALPG P10696 1/20 0.37
ALOX12 P18054 1/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109232 0.86 HTT (0.33) HTTUSP2ALDH1A1GAAMEN1
SCHEMBL17595817 0.84 HTT (0.44) HTTUSP2ALDH1A1GAAMEN1
SCHEMBL20113463 0.83 HTT (0.43) HTTUSP2ALDH1A1GAAMEN1
SCHEMBL20109214 0.76 CHRNA7 (0.36) MAPTCYP3A4
SCHEMBL20109151 0.71 HTT (0.34) HTTUSP2ALDH1A1MEN1KMT2A
SCHEMBL20109255 0.70 HTT (0.33) HTTUSP2ALDH1A1MEN1KMT2A
SCHEMBL20109230 0.69 GAA (0.34) ALDH1A1GAAKMT2ANPSR1MAPT
SCHEMBL20113904 0.69 MAPT (0.39) ALDH1A1GAAMEN1KMT2AMAPT
SCHEMBL20113728 0.68 USP2 (0.47) HTTUSP2ALDH1A1GAAMEN1
SCHEMBL20113452 0.68 USP2 (0.47) HTTUSP2ALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 HTT 1494/4885USP2 4368/4885ALDH1A1 4621/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 HTT 1494/4885USP2 4368/4885ALDH1A1 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.